Low Level laser Therapy (LLLT) Cold Laser - THOR Laser

Do More With A THOR
Lots of happy THOR customer testimonials
NovoTHOR Whole Body Light Pod

Photobiomodulation (PBM Therapy) Safety

Some THOR products are class 3B lasers (others are LED's).

Class 3B lasers are potentially hazardous to the eye.

Never stare into the beam or direct the beam into the eyes of others.

THOR lasers are not collomated, they are divergent, this means that the beam expands and becomes less hazardous the futher away you get from the treatment prob aperture.  

The Nominal Ocular Hazard Distance (NOHD) for our 810nm 200mW lasers has been calculated to be 1.15 meters.

NOHD is the distance at which the laser output is safe to view without safety spectacles.

i.e. below the Maximum Permissible Exposure (MPE).

All people present in the treatment area should wear appropriate laser safety eye wear.

What is appropriate ?

Laser safety eyewear should match the laser wavelength and have sufficient optical density at that wavelength to protect the eye.

THOR offer laser safety eyewear for sale that matches the laser wavelength / powers offered and meet ISO recomendations.

For more information on laser safety:

For more information, visit THOR Laser Home



OUR CUSTOMERS INCLUDE:
Our customers include: Harvard Medical School, Massachusetts General Hospital, British Army, RAF, Royal Navy, Team GB, Manchester United, MIT, Harvard School of Public Health, Cedars Sinai, City of Hope, USUHS
THOR Customers

THOR Photomedicine Ltd is an ISO 13485:2016 certified medical device company.

The THOR LX2.3 Photobiomodulation system has a medical CE mark (EC certificate). It is indicated for oral mucositis, tendinopathies, joint pain, neck pain and back pain for marketing in the UK, EU and Australia.

The THOR LX2.3 Photobiomodulation system is also FDA Cleared for marketing in the United States for: Temporary increase in local blood circulation, temporary relief of minor muscle and joint aches, pains and stiffness and relaxation of muscles; for muscle spasms, and minor pain and stiffness associated with arthritis.

Excluding the THOR LED Helmet, THOR LX2 and NovoTHOR systems are manufactured under conditions fulfilling the quality system requirements of Annex II, excluding (4), of the directive 93/42/EEC as amended and satisfy the applicable international harmonised standards.

Positive systematic reviews published by:

The British Medical Journal (BMJ), The Lancet, the International Association for the Study of Pain (IASP), the World Health Organisation (WHO), the Multinational Association for Supportive Care in Cancer (MASCC), the European Society for Medical Oncology (ESMO)

Appropriate regulatory clearance or approvals include:

Quality certificates